To study the mechanism of the intrahepatic cholestasis observed during total parenteral nutrition (TPN) in neonates, we examined the localization of IgA, secretory component (SC) and complement component C3 (C3) in the liver in 4 patients by light and electron microscopic immunohisto chemistry. In the patients who received TPN for 1 month, IgA and SC positive cholestasis was limited to bile canaliculi, but the integrity of both the canalicular wall and intercellular tight junction was maintained. These findings suggest that obstruction in the biliary tract develops at the canalis of Hering, causing reflux of IgA and SC into the bile canaliculi. When the duration of TPN extended beyond 6 months, the cholestasis in bile canaliculi progressed further, and degeneration of hepatocytes became more marked. Bile retained in hepatocytes occasionally contained IgA and SC. IgA and SC-positive cholestasis also developed in the interlobular bile ducts, where no cholestasis had been observed 1 month after the beginning of TPN. SC production and SC-mediated transport of IgA, which are important functions of bile duct epithelial cells in the local immune mechanism, were impaired in association with the injury of those cells. C3 was localized not only in the hepatocellular organelles where C3 is normally observed, but also in the lumen of dilated bile canaliculi, suggesting that C3 is released from hepatocytes into bile in neonates receiving TPN and that C3 may be involved in some local immune mechanism of biliary system.
Introduction
Total parenteral nutrition (TPN) is a technique indis pensable for alimentary support also in pediatric surgery. However, this essentially unphysiologic procedure has been reported to have problems concerning its technical aspects and its management, as well as various metabolic and nutritional complications. In particular, prolonged TPN in neonates is likely to induce cholestatic liver injury, and cases dependent on TPN eventually develop often fatal hepatic failure.
We have performed TPN in 66 neonates who under went surgery and observed liver dysfunction accom panied by hyperbilirubinemia in 29 cases (44%). Five of these patients could not be weaned from TPN and died of hepatic failure. The mechanism of intrahepatic chol estasis associated with TPN remains largely obscure and its management is still difficult.
In the present study, we investigated the mechanism of intrahepatic cholestasis in neonates undergoing TPN by examining intrahepatic localization of IgA, SC and C3.
Materials and Methods
We performed TPN in 66 (11%) of 412 surgical neonates encountered during the past 13 years . The procedure was administered for 1 month or longer in 33, and liver dysfunction accompanied by hyperbilirubinemia was observed in 25 (75%) of these patients . The following evaluations were carried out in 4 of these patients . TPN consisted of water (100-120ml/kg/day) , amino acid (2g/kg/day, E/N ratio=1), and glucose and fat (1-2g/kg/day). The patients were 2 male and 2 female full-term neonates. Their primary diseases were ileal 
Results
In Case 1 receiving TPN for 1 month, the serum bilirubin and transaminase levels were normal, but IgA and SC-positive bile was already found in dilated bile canaliculi (Fig 1) . There was no difference in the local ization of IgA and SC. Microvilli were degenerated or lost in some of the markedly dilated bile canaliculi, and their walls were slightly thickened (Fig 2) . Both IgA and SC were also observed in bile canaliculi showing little dilatation (Fig 3) . No reaction product was found in hepatocytes, and no marked changes were observed in organelles. Interlobular bile ducts showed normal local ization of IgA and SC, and no cholestasis was noted in their lumens. C3 was localized in dilated bile canaliculi, in addition to the endoplasmic reticulum, Golgi apparatus, and vesicles of hepatocytes. However, the integrity of the bile canalicular wall, including tight junction, remained almost normal (Fig 4) .
In case 4 receiving TPN for 28 months, fatty degener ation of hepatocytes, and fibrosis and cell infiltration of the portal area were observed. IgA-and SC-positive cholestasis developed extensively from hepatocytes to interlobular bile ducts (Fig 5) . Many of the bile canaliculi that could be examined showed remarkable dilatation and thickening of the wall and contained IgA and SC -positive substances in their lumens, but these findings were essentially the same as in case 1 (Fig 6) . In hepato cytes, swelling, dissociation, and loss of organelles were notable, and the cell membrane was obscured. Some hepatocytes contained IgA-and SC-positive substances in the cytoplasm. Interlobular bile ducts also showed remarkable stagnation of IgA-and SC-positive bile. Their lumens were irregularly narrowed, and microvilli were nearly obliterated (Fig 7) . SC was observed in the When the duration of TPN was extended beyond 6 months, cholestasis in bile canaliculi further progressed and degeneration of hepatocytes, including the bile cana licular wall, became more notable. Bile retained in hepa tocytes occasionally contained IgA and SC. Although the route of its entry could not be determined, it waaas considered to have entered the cells via the damaged bile canalicular wall. Injury of hepatocyte organelles was also marked, and few cells appeared to be capable of functioning as hepatocytes. IgA-and SC-positive cho lestasis developed also in the interlobular bile ducts, where no cholestasis was observed 1 month after the beginning of TPN. SC production and SC-mediated transport of IgA, which are important functions of bile duct epithelial cells, were impaired with the injury and degeneration of those cells. Since the bile ducts were scarcely dilated, cholestasis in the portal region is unlikely to be due to obstruction of distal bile ducts. Although the causative relationship between cholestasis and injury of bile duct epithelial cells must still be clarified, our findings suggest a vicious circle in which extensive fun ctional impairment of bile duct epithelial cells first induces cholestasis, and toxic factors in the retained bile, such as bile acids, then damage epithelial cells.
The complement component C3 is produced primarily in the hepatocyte, and the serum C3 level is reported to increase in patients with obstructive jaundice.21,22 The behavior of intrahepatic C3 during cholestasis due to TPN is of profound interest. In addition to the normal localization of C3 in the organelles, it was observed also in the bile of dilated bile canaliculi. Oshio et al22 ascribed the increase of C3 in bile in patients with obstructive jaundice to damaged hepatocytes. Our results appear to partly support this view. Among complement com ponents, C3 is considered to be released from hepato cytes into bile in neonates receiving TPN and to be involved in some local immune mechanism of the biliary system.
